UPCOMING

Join us for
our roundtable in
||
latest advances in
||
your questions on
||
new therapies for
||
practice changes in
||
your patient cases in

LUNG CANCER

Solange Peters

Lausanne University Hospital, Switzerland

Hossein Borghaei

Fox Chase Cancer Center, Philadelphia, USA

Marina Garassino

University of Chicago, Illinois, USA

AGENDA

WELCOME & INTRODUCTION BY HOST

Solange Peters

Druggable since 2024: an overview of newly approved therapies for NSCLC

Solange Peters

Highlights of the year in targeted therapies

Marina Garassino

Highlights of the year in immunotherapies

Hossein Borghaei

ï•™

2 CME Points

SGMO • SSOM • SSMO

Join our host, Solange Peters, for an insightful roundtable on the latest advancements in the treatment of lung cancer. This interdisciplinary event gathers renowned experts to discuss groundbreaking findings from the past year, offering an in-depth exploration of new innovative therapeutic approaches. The discussion will cover key topics including newly approved therapies for NSCLC, highlights of the year in targeted therapies, and advancements in immunotherapies. Don’t miss this opportunity to enhance your understanding, engage in the discussion, and uncover the pivotal developments transforming the landscape of lung cancer treatment.

Register here

Do You Have An Account Already?
No need to sign up again: as a verified OncoViewer, you will have access to all our upcoming sessions. Simply login to participate in this session.


First Time On OncoViews?

Get Registered Now

 

This session is kindly supported by our partners with no influence on the content

AstraZeneca
MSD
BeiGene
Roche
JnJ